Company overview
Basic information
Company name
Bioasas, MB
Company code
304436806
VAT code
LT100010624417
Registered address
Radviliškis, A. Povyliaus g. 4-1, LT-82162
Registration date
2016-12-28
Company age: 9 y. 10 mo.
Contact information
Edit data
Phone
Presented as an image – cannot be copied
Presented as an image – cannot be copied
Email
Not disclosed
(personal)
Website
None
Company manager
For registered members only
Log in
Indicators
Risk factors
Activity
Legal form
Small partnership
NACE activity
Intermediation service activities for business support service activities n.e.c.
Ownership form
Private without foreign capital
MB "Bioasas"
Company code: 304436806
Address: Radviliškis, A. Povyliaus g. 4-1, LT-82162
VAT code: LT100010624417
Description
This description was generated by artificial intelligence.
Bioasas, MB (company code 304436806) is an operational private small partnership registered in 2016. It operates under private ownership, where Lithuanian natural and legal persons hold more than 50% of the authorised capital and there is no foreign investor capital. Governance is described as CEO only, and the company is classified among national private non-financial companies. It is a micro-sized entity. The registered address is Radviliškis, A. Povyliaus g. 4-1, Radviliškio r. sav., Šiauliu apskr. The company’s activity is coded EVRK O.82.40.00, intermediation service activities for business support service activities n.e.c. Financially, revenue increased from €11.5K in 2023 to €18.0K in 2024 and €19.0K in 2025. The business remained loss-making throughout the period, with net profit of -€301 in 2023, -€556 in 2024 and -€413 in 2025, showing a smaller loss in the latest year. Equity stayed negative, and total assets were very small, falling to €929 in 2025. Staff data are available so far in 2026, but no average employee count is specified.
Download a detailed company report
Make confident decisions with all the information about Bioasas, MB. In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.